Making The ChIP Antibody GradesMarch 29, 2011Back in the 2000’s most researchers spent their post-ChIP analysis looking at a gel or a PCR curve. Now, they spend their analysis time combing through hard drives of sequencing data. A lot has changed in the world of location analysis, but the need for good antibodies remains the same; which is probably why we […]
LincRNA HOTTIP Gives Inside Info on Active Chromatin MarketsMarch 24, 2011In unsteady stock markets these days, who couldn’t use a hot tip to rev up their investments? Apparently, some HOXA genes also need a HOTTIP just as much as any Wall St. insider to help jump-start production. A recent Nature paper from talented teams at Stanford University and UCSF reveals that a long intergenic non-coding […]
Epigenetics in Evolution with Dr Eva JablonkaMarch 13, 2011Dr. Eva Jablonka discusses the role of epigenetics in evolutionary biology. This short take was shot during a break at Keystone Symposia’s meeting on Environmental Epigenomics and Disease Susceptibility held in March 2011 in Asheville, North Carolina. Epigenetics in Evolution Well, what I’m doing really is theoretical work, and I’m mainly interested in the evolutionary […]
5-Azacytidine: The Charlie Sheen of DNA Methylation Inhibitors?March 13, 2011As we’ve all recently witnessed, some actors have polished public images but are a mess in real life. After reading two recent papers by groups in Los Angeles and Turkey, it sounds like the same could be said of 5-azacytidine (Vidaza®). Mounds of clinical data now show that 5-azacytidine is a good treatment for blood […]
Enoxacin: The Undercover Cancer Fighter Rouses Dormant miRNAsMarch 11, 2011By day, it’s known as a mild-mannered antibiotic. But secretly, enoxacin may also have the power to take down cancer, which had remained hidden until now. A study just published in PNAS found that enoxacin, which is normally used to treat urinary tract infections, also prevents the growth and metastasis of colorectal tumors in mice. […]
